What is New on Thyroid Cancer Biomarkers
Thyroid cancer harbours in about 5% of thyroid nodules. The majority of them are well-differentiated cancers originating from the follicular epithelium, and are subdivided into papillary and follicular carcinomas. Undifferentiated carcinomas and medullary thyroid carcinomas arising from C cells are...
Main Authors: | Maria Trovato, Francesco Trimarchi, Sergio Baldari, Rosaria M. Ruggeri, Alfredo Campennì |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2008-01-01
|
Series: | Biomarker Insights |
Subjects: | |
Online Access: | http://la-press.com/article.php?article_id=762 |
Similar Items
-
What is New on Thyroid Cancer Biomarkers
by: Rosaria M. Ruggeri, et al.
Published: (2008-01-01) -
A Clinico-Cytological Study of Thyroid Lesions in a Tertiary Care Centre in North Karnataka with Thyroid Function Test Correlation
by: Dimple Mehrotra, et al.
Published: (2016-10-01) -
Ultrasonographic Evaluation of Thyroid Nodules with Pathologic Correlation
by: Gururaj Sharma, et al.
Published: (2017-04-01) -
Correlation of fine needle aspiration cytology with histopathology findings in cases of thyroid lesions in Bir Hospital
by: PB Thapa, et al.
Published: (2014-01-01) -
To screen or not to screen for medullary thyroid cancer? This is (yet) the question. An illustrative case.
by: Rosaria Ruggeri, et al.
Published: (2018-12-01)